Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.
about
Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.
@en
Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.
@nl
type
label
Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.
@en
Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.
@nl
prefLabel
Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.
@en
Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.
@nl
P2093
P2860
P356
P1476
Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.
@en
P2093
Gregory Brill
Jerry Avorn
Jessica M Franklin
Michael A Fischer
Niteesh K Choudhry
Olga S Matlin
Sebastian Schneeweiss
Troyen A Brennan
William H Shrank
P2860
P304
P356
10.2105/AJPH.2013.301762
P407
P577
2014-04-17T00:00:00Z